Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

Bernard Nordlinger(Assistance Publique – Hôpitaux de Paris), Halfdan Sørbye(Haukeland University Hospital), Bengt Glimelius(Uppsala University), Graeme J. Poston(University of Liverpool), Peter M. Schlag(Charité - Universitätsmedizin Berlin), Philippe Rougier(Assistance Publique – Hôpitaux de Paris), Wolf O. Bechstein(Goethe University Frankfurt), John N Primrose(Southampton General Hospital), Euan Walpole(The University of Queensland), Meg Finch-Jones(University Hospitals Bristol NHS Foundation Trust), Daniel Jaeck(Hôpital d'Hautepierre), Darius Mirza(NIHR Surgical Reconstruction and Microbiology Research Centre), Rowan W. Parks(Edinburgh Royal Infirmary), Murielle Mauer(European Organisation for Research and Treatment of Cancer), E. Tanis(European Organisation for Research and Treatment of Cancer), Eric Van Cutsem(KU Leuven), Werner Scheithauer(Comprehensive Cancer Center Vienna), Thomas Gruenberger(Comprehensive Cancer Center Vienna)
The Lancet Oncology
October 10, 2013
Cited by 1,311

Abstract


Related Papers

No related papers found

Powered by citation graph analysis